Rising biosimilar adoption, shifting market dynamics, and escalating supply chain vulnerabilities are driving change in ...
In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.
The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
Crinetics Pharma's Paltusotine shows strong Phase 3 results for acromegaly. Click here to find out why CRNX stock is a Buy.
Phathom Pharmaceuticals, Inc.’s PHAT share price has surged by 11.72%, which has investors questioning if this is right time to sell.
Boehringer Ingelheim picked a challenging day to reveal its 2024 financial results and guidance for this year. | Boehringer ...
Europe’s pharmaceutical sector is bracing for the potential impact of U.S. tariffs as hopes of an industry-wide exemption by President Donald Trump fade.
Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...
At least 63 biopharma layoff rounds were conducted in the first quarter of this year, with cell and gene biotechs accounting ...
A massive global analysis reveals pharmaceuticals as the most carbon-intensive portion of the global health care system ...
VnExpress International on MSN1d
Vietnamese student, driven by father's battle with Parkinson's, wins PhD pharmaceutical scholarship in SingaporeDetermined to pursue research after her father's passing from Parkinson's disease, a student in Hanoi has earned a PhD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback